Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,816 | -28,323 | -28,669 | -30,699 | -21,622 |
| Depreciation Amortization | 936 | 929 | 1,604 | 1,879 | 1,538 |
| Accounts receivable | 186 | -956 | -1,424 | 1,996 | -4,028 |
| Other Working Capital | 1,539 | 353 | -5,629 | -877 | -5,833 |
| Other Operating Activity | 1,702 | 5,388 | 8,318 | 5,341 | 9,371 |
| Operating Cash Flow | $-23,453 | $-22,609 | $-25,800 | $-22,360 | $-20,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -32 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -561 | -350 |
| Other Investing Activity | 0 | 0 | 0 | -561 | -350 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-593 | $-350 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 7,273 | N/A | N/A |
| Debt Repayment | -2,560 | -912 | -44 | N/A | -9,317 |
| Common Stock Issued | 62,151 | 2,668 | 263 | 6,433 | 103,680 |
| Other Financing Activity | -4,895 | 0 | -461 | -485 | -6,930 |
| Financing Cash Flow | $54,696 | $1,756 | $7,031 | $5,948 | $87,433 |
| Exchange Rate Effect | -2,544 | 549 | -1,866 | 244 | 2,604 |
| Beginning Cash Position | 26,213 | 46,517 | 67,152 | 83,913 | 14,800 |
| End Cash Position | 54,912 | 26,213 | 46,517 | 67,152 | 83,913 |
| Net Cash Flow | $28,699 | $-20,304 | $-20,635 | $-16,761 | $69,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,453 | -22,609 | -25,800 | -22,360 | -20,574 |
| Capital Expenditure | N/A | N/A | N/A | -32 | N/A |
| Free Cash Flow | -23,453 | -22,609 | -25,800 | -22,392 | -20,574 |